AlphaGenome, accessible via API, cracks the “junk DNA” code, outperforms top rivals in key tests, and puts advanced genomics ...

Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validat ...

The research discusses various LLM architectures, including encoder-only models like DNABERT, decoder-only models such as DNAGPT, and encoder-decoder models like ENBED.

Background: Direct circulating tumor cell (CTC) detection is a promising biomarker for early cancer detection and monitoring. Traditional fluorescence microscopy and AI-driven methods have limitations ...

Glioma survival risk prediction is of great significance for the individualized treatment and assessment programs. Currently, most deep learning based survival prediction paradigms rely on invasive ...

Among IDT’s most transformative innovations are tools that have significantly advanced genomics and molecular biology. One such innovation launched in 2012 is gBlocks, the first commercially ...

Dr. Aleix Prat, Co-Founder and Chief Scientific Officer of REVEAL GENOMICS, identified ONA-255 drug target and currently leads the advisory board of Ona Therapeutics. REVEAL GENOMICS will lead the ...

Looking to the future, cancer care is now advancing from genomics to multiomics—the integration of diverse biological datasets, including clinical, biological, genomic and imaging data—to ...

The brain encoder then learns to align MEG signals to these image embeddings. Finally, the image decoder generates a plausible image based on these brain representations.